(Total Views: 468)
Posted On: 08/06/2020 9:04:06 PM
Post# of 653
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Re: ClosetInvestor #3
Perhaps it will perform like CYDY did. After all their frontman has a medical "pedigree".
The trials are being done in conjunction with NeuroRx, whose principal's bio is below, what an impressive background.
Chief Executive Officer Jonathan C. Javitt, M.D., M.P.H.
Dr. Javitt has played leadership roles in seven successful healthcare IT and biopharma startups with public exits. He has additionally led drug-development engagements for Merck, Allergan, Pharmacia, Novartis, and Pfizer. He was appointed to healthcare leadership roles under Presidents Reagan, George H.W. Bush, Clinton, and George W. Bush. In the latter role he was commissioned to lead the White House policy for universal adoption of Health IT and establishment of the Office of the National Coordinator. He is a graduate of Princeton University, Cornell University Medical College, Harvard School of Public Health, the Wills Eye Hospital, and Johns Hopkins Medical School . Dr. Javitt has published more than 200 scientific works in the areas of health outcomes and pharmacoeconomics that have been cited by more than 16,000 people.
And have you listened to him -
https://www.youtube.com/watch?v=lgmpS2N8124
The trials are being done in conjunction with NeuroRx, whose principal's bio is below, what an impressive background.
Chief Executive Officer Jonathan C. Javitt, M.D., M.P.H.
Dr. Javitt has played leadership roles in seven successful healthcare IT and biopharma startups with public exits. He has additionally led drug-development engagements for Merck, Allergan, Pharmacia, Novartis, and Pfizer. He was appointed to healthcare leadership roles under Presidents Reagan, George H.W. Bush, Clinton, and George W. Bush. In the latter role he was commissioned to lead the White House policy for universal adoption of Health IT and establishment of the Office of the National Coordinator. He is a graduate of Princeton University, Cornell University Medical College, Harvard School of Public Health, the Wills Eye Hospital, and Johns Hopkins Medical School . Dr. Javitt has published more than 200 scientific works in the areas of health outcomes and pharmacoeconomics that have been cited by more than 16,000 people.
And have you listened to him -
https://www.youtube.com/watch?v=lgmpS2N8124
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)